REELIN THERAPEUTICS, INC.
San Diego, CA · Biotech · Private
Anti-Reelin monoclonal antibodies for depleting plasma Reelin to reduce vascular adhesion molecule expression in rheumatoid arthritis
- Grants
- $1.5M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A novel role for Reelin therapeutics in inflammatory bowel disease | $400,032 | |
| Federal grant | Department of Health and Human Services · Phase I · A novel role for Reelin therapeutics in rheumatoid arthritis | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Effect of APP copy number variants in Alzheimer's disease and and Down Syndrome on Reelin expression and function | $259,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Effect of APP copy number variants in Alzheimer's disease and and Down Syndrome on Reelin expression and function | $238,549 | |
| Federal grant | Department of Health and Human Services · Phase I · Identification of next generation gamma-secretase modulators for Alzheimer's disease | $258,213 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1617 | Provizigen LLC | — | — |
| 1618 | ALZHEON, INC. | — | $134M |
| 1619 | Repair Biotechnologies, Inc. | — | $25M |
| 1620 | REELIN THERAPEUTICS, INC. | — | — |
| 1621 | DASFANH BIOSCIENCES, LLC | — | — |
| 1622 | Verdiva Bio | — | — |
| 1623 | Furtim Therapeutics LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.